Founder, Nelsen Biomedical
Barbara Nelsen is the founder Nelsen Biomedical, a market research and strategic consulting firm with offices in Minneapolis and Boston. She brings more than 20 years of experience providing technology and opportunity assessment, strategic planning and partnering, market expansion and commercialization plans. Clients range from start-ups to well-established life sciences companies, investment firms and research institutions.
She is currently on the Board of Discovery Capital, the University of Minnesota’s venture fund and also on the Board of Directors for B-MoGen Biotechnologies. She is the co-founder of Emerge Bioscience, providing career training and development programs for scientists.
Barbara has truly sat on all sides of the table. She has been an investor, (Sofia Fund) and a scientific investigator (Brandeis University, The Whitehead Institute). She has worked in industry in research and development (Director, Cancer Therapeutics and Diagnostics the Austin Institute Australia) and in business development (MGI Pharma).
Barbara holds a Ph.D. in molecular biology and an MBA.